Literature DB >> 18813167

Acute traumatic intraparenchymal hemorrhage: risk factors for progression in the early post-injury period.

Edward F Chang1, Michele Meeker, Martin C Holland.   

Abstract

OBJECTIVE: To characterize the natural course of traumatic intraparenchymal contusions and hematomas (IPHs) and to identify risk factors for IPH progression in the acute post-injury period.
METHODS: A retrospective analysis was performed on a prospective observational database containing 113 head trauma patients exhibiting 229 initially nonoperated acute IPHs. The main outcome variable was radiographic evidence of IPH progression on serially obtained head computed tomographic (CT) scans. Secondary outcomes included the actual amount of IPH growth and later surgical evacuation. Univariate and multivariate analyses (using a generalized estimate equation) were applied to both demographic and initial radiographic features to identify risk factors for IPH progression and surgery.
RESULTS: Overall, 10 IPHs (4%) shrank, 133 (58%) remained unchanged, and 86 (38%) grew between the first and second head CT scan. IPH progression was independently associated with the presence of subarachnoid hemorrhage (odds ratio [OR], 1.6; 95% confidence interval [CI], 1.12-2.3), presence of a subdural hematoma (OR, 1.94; 95% CI, 1.1-3.43), and initial size (OR, 1.11; 95% CI, 1.02-1.21, for each cm volume). Size of initial IPH proportionately correlated with the amount of subsequent growth (linear regression, P < 0.001). Worsened Glasgow Coma Score between initial and follow-up head CT scan (OR, 8.6; 95% CI, 1.5-50), IPH growth greater than 5 cm (OR, 7.3; 95% CI, 1.6-34), and effacement of basal cisterns on initial CT scan (OR, 9.0; 95% CI, 1.5-52) were strongly associated with late surgical evacuation.
CONCLUSION: A large proportion of IPHs progress in the acute post-injury period. IPHs associated with subarachnoid hemorrhage, a subdural hematoma, or large initial size should be monitored carefully for progression with repeat head CT imaging. Effacement of cisterns on the initial head CT scan was strongly predictive of failure of nonoperative management, thereby leading to surgical evacuation. These findings should be important factors in the understanding and management of IPH.

Entities:  

Year:  2007        PMID: 18813167     DOI: 10.1227/01.neu.0000279217.45881.69

Source DB:  PubMed          Journal:  Neurosurgery        ISSN: 0148-396X            Impact factor:   4.654


  13 in total

1.  Relationship between Measures of Cerebrovascular Reactivity and Intracranial Lesion Progression in Acute Traumatic Brain Injury Patients: A CENTER-TBI Study.

Authors:  François Mathieu; Frederick A Zeiler; Ari Ercole; Miguel Monteiro; Konstantinos Kamnitsas; Ben Glocker; Daniel P Whitehouse; Tilak Das; Peter Smielewski; Marek Czosnyka; Peter J Hutchinson; Virginia F J Newcombe; David K Menon
Journal:  J Neurotrauma       Date:  2020-04-01       Impact factor: 5.269

2.  Optimal surgical indications of endoscopic surgery for traumatic acute subdural hematoma in elderly patients based on a single-institution experience.

Authors:  Koichi Miki; Masani Nonaka; Hiromasa Kobayashi; Yoshinobu Horio; Hiroshi Abe; Takashi Morishita; Mitsutoshi Iwaasa; Tooru Inoue
Journal:  Neurosurg Rev       Date:  2020-07-23       Impact factor: 3.042

Review 3.  Utility of platelet transfusion in adult patients with traumatic intracranial hemorrhage and preinjury antiplatelet use: a systematic review.

Authors:  Daniel K Nishijima; Shahriar Zehtabchi; Jeanette Berrong; Eric Legome
Journal:  J Trauma Acute Care Surg       Date:  2012-06       Impact factor: 3.313

4.  Traumatic intracranial hematomas: prognostic value of contrast extravasation.

Authors:  L Letourneau-Guillon; T Huynh; R Jakobovic; R Milwid; S P Symons; R I Aviv
Journal:  AJNR Am J Neuroradiol       Date:  2012-10-18       Impact factor: 3.825

5.  The profile of blunt traumatic infratentorial cranial bleed types.

Authors:  Isaac Ng; Nikolay Bugaev; Ron Riesenburger; Aaron C Shpiner; Janis L Breeze; Sandra S Arabian; Reuven Rabinovici
Journal:  J Clin Neurosci       Date:  2018-10-17       Impact factor: 1.961

6.  Mismatch between midline shift and hematoma thickness as a prognostic factor of mortality in patients sustaining acute subdural hematoma.

Authors:  Matheus Rodrigues de Souza; Caroline Ferreira Fagundes; Davi Jorge Fontoura Solla; Gustavo Carlos Lucena da Silva; Rafaela Borin Barreto; Manoel Jacobsen Teixeira; Robson Luis Oliveira de Amorim; Angelos G Kolias; Daniel Godoy; Wellingson Silva Paiva
Journal:  Trauma Surg Acute Care Open       Date:  2021-05-21

Review 7.  Enduring Neuroprotective Effect of Subacute Neural Stem Cell Transplantation After Penetrating TBI.

Authors:  Anelia A Y Kassi; Anil K Mahavadi; Angelica Clavijo; Daniela Caliz; Stephanie W Lee; Aminul I Ahmed; Shoji Yokobori; Zhen Hu; Markus S Spurlock; Joseph M Wasserman; Karla N Rivera; Samuel Nodal; Henry R Powell; Long Di; Rolando Torres; Lai Yee Leung; Andres Mariano Rubiano; Ross M Bullock; Shyam Gajavelli
Journal:  Front Neurol       Date:  2019-01-17       Impact factor: 4.086

8.  Risk factors associated with the progression of extra-axial hematoma in the original frontotemporoparietal site after contralateral decompressive surgery in traumatic brain injury patients.

Authors:  Peng Chen; Yong-Bing Deng; Xi Hu; Wei Zhou; Qing-Tao Zhang; Lian-Yang Zhang; Min-Hui Xu
Journal:  Chin J Traumatol       Date:  2020-01-03

9.  Natural course of initially non-operated cases of acute subdural hematoma : the risk factors of hematoma progression.

Authors:  Seong Son; Chan Jong Yoo; Sang Gu Lee; Eun Young Kim; Chan Woo Park; Woo Kyung Kim
Journal:  J Korean Neurosurg Soc       Date:  2013-09-30

10.  Relationship Between Measures of Cerebrovascular Reactivity and Intracranial Lesion Progression in Acute TBI Patients: an Exploratory Analysis.

Authors:  François Mathieu; Frederick A Zeiler; Daniel P Whitehouse; Tilak Das; Ari Ercole; Peter Smielewski; Peter J Hutchinson; Marek Czosnyka; Virginia F J Newcombe; David K Menon
Journal:  Neurocrit Care       Date:  2020-04       Impact factor: 3.210

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.